Salisbury Bancorp Inc. (NASDAQ:SAL) ended the last trading day at $32.31. Company weekly volatility is calculated as 1.34% and price to cash ratio as 1.04. Salisbury Bancorp Inc. (NASDAQ:SAL) showed a weekly performance of 4.09%.
On 10 December, Salisbury Bancorp Inc. (NASDAQ:SAL) announced the completion of a private placement of $10.0 million in aggregate principal amount of fixed to floating rate subordinated notes to various accredited investors including certain of Salisbury’s directors.
On 18 December, Glu Mobile, Inc. (NASDAQ:GLUU) shares decreased -1.01% and was closed at $2.95. GLUU EPS growth in last 5 year was 16.30%. Glu Mobile, Inc. (NASDAQ:GLUU) year to date (YTD) performance is -24.36%.
Glu Mobile, Inc. (NASDAQ:GLUU) announced the availability of the new mobile game, Katy Perry Pop, on the App Store and Google Play. Under the creative direction of Katy Perry herself, the game features Katy’s likeness, voice, and in-game video clips as she guides players on their journey to success in the music industry.
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) shares increased 10.93% in last trading session and ended the day at $5.38. KERX Gross Margin is 37.60% and its has a return on assets of -78.40%. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) quarterly performance is 35.18%.
On 10 December, Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) announced that John P. Butler has been appointed as a new independent director to its board of directors pursuant to the company’s financing transaction with The Baupost Group, L.L.C., effective immediately. Mr. Butler is an industry veteran with significant experience in guiding corporate strategy.
Horizon Pharma plc (NASDAQ:HZNP) shares decreased -2.39% in last trading session and ended the day at $20.79. HZNP Gross Margin is 70.00% and its has a return on assets of -0.70%. Horizon Pharma plc (NASDAQ:HZNP) quarterly performance is -28.29%.
On 11 December, Horizon Pharma plc (NASDAQ:HZNP) announced it has entered a definitive agreement to acquire Crealta Holdings LLC for $510 million in cash. The Crealta acquisition further diversifies our portfolio of medicines and aligns with our focus of acquiring value-enhancing, clinically differentiated, long-life medicines that treat orphan diseases,” said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma pl
KeyCorp. (NYSE:KEY) caters to the Financial space. It has a net profit margin of 35.50% and weekly performance is -0.55%. On the last day of trading company shares ended up at $12.67. KeyCorp. (NYSE:KEY) distance from 50-day simple moving average (SMA50) is -2.90%.
KeyCorp (NYSE:KEY) said that, it will keep and expand First Niagara Financial Group’s Buffalo, N.Y.-based mortgage operations to spur along its return to being a player in residential lending.
Leave a Reply